中国生物制药(01177.HK)：ESG表现获得标普全球、富时罗素认可

格隆汇资讯07-19

格隆汇7月19日丨中国生物制药(01177.HK)宣布，集团凭借持续且稳定的环境、社会及企业管治(ESG)实践表现，已获得标普全球(S&P Global)、富时罗素(FTSE Russell)等多家全球可持续发展权威机构的认可。2024年7月，集团凭借在标普全球企业可持续发展评估(CSA)中的优异表现，从1,700余家企业中脱颖而出，成功入选标普全球《可持续发展年鉴(中国版)2024》，成为各行业...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2452441380?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-19 16:35","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2452441380","market":"us","top_or_hot":-1,"title":"中国生物制药(01177.HK)：ESG表现获得标普全球、富时罗素认可","media":"格隆汇资讯","content":"<div>\n<p>格隆汇7月19日丨中国生物制药(01177.HK)宣布，集团凭借持续且稳定的环境、社会及企业管治(ESG)实践表现，已获得标普全球(S&P Global)、富时罗素(FTSE Russell)等多家全球可持续发展权威机构的认可。2024年7月，集团凭借在标普全球企业可持续发展评估(CSA)中的优异表现，从1,700余家企业中脱颖而出，成功入选标普全球《可持续发展年鉴(中国版)2024》，成为各行业...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071916360595dba3b4&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中国生物制药(01177.HK)：ESG表现获得标普全球、富时罗素认可</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中国生物制药(01177.HK)：ESG表现获得标普全球、富时罗素认可\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-19 16:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071916360595dba3b4&s=b><strong>格隆汇资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇7月19日丨中国生物制药(01177.HK)宣布，集团凭借持续且稳定的环境、社会及企业管治(ESG)实践表现，已获得标普全球(S&P Global)、富时罗素(FTSE Russell)等多家全球可持续发展权威机构的认可。2024年7月，集团凭借在标普全球企业可持续发展评估(CSA)中的优异表现，从1,700余家企业中脱颖而出，成功入选标普全球《可持续发展年鉴(中国版)2024》，成为各行业...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071916360595dba3b4&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0971096721.USD","symbol_name":"富达环球金融服务 A","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071916360595dba3b4&s=b","article_id":"2452441380","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071916360595dba3b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2452441380","pubTimestamp":1721378152,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"格隆汇7月19日丨中国生物制药宣布，集团凭借持续且稳定的环境、社会及企业管治实践表现，已获得标普全球、富时罗素等多家全球可持续发展权威机构的认可。CSA是全球规模最大的企业可持续发展实践年度评估之一。目前，集团CSA评分已稳步提升至55分，超过全球92%的同业企业，处于国际领先水平。集团首次入选FTSE4Good指数并连续第二年入选标普全球《可持续发展年鉴(中国版)》，代表着国际资本市场专业机构对集团ESG实践表现的持续、高度认可。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0971096721.USD":"富达环球金融服务 A","ESG":"FlexShares STOXX US ESG Select Index Fund","SG9999001077.SGD":"United International Growth Fund SGD","SG9999014898.SGD":"United Global Quality Growth Fund Dis SGD","SRTY":"罗素2000指数三倍做空ETF-ProShares","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","LU1989763005.USD":"东方汇理教育基金A2 Acc","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","RWM":"罗素2000指数反向ETF","01177":"中国生物制药","SGXZ31699556.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"C\" (SGDHDG) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","TNA":"罗素2000指数三倍做多ETF-Direxion","IWM":"罗素2000指数ETF","BK4535":"淡马锡持仓","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","TWM":"罗素2000指数两倍做空ETF","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","SG9999014880.SGD":"大华全球优质成长基金Acc SGD","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU1989773731.SGD":"CPR Invest - Education A2 Acc SGD-H","IWN":"罗素2000价值股指数ETF-iShares","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","SG9999018865.SGD":"United Global Quality Growth Fd Cl Dist SGD-H","IWO":"罗素2000成长股指数ETF","BK4588":"碎股","BK4581":"高盛持仓","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","SPGI":"标普全球","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","SG9999018857.SGD":"United Global Quality Growth Fd Cl Acc SGD-H","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU1496350502.SGD":"FRANKLIN DIVERSIFIED DYNAMIC \"A\" (SGDHDG) ACC","LU1633808545.USD":"ALLIANZ GLOBAL EQUITY GROWTH \"AT\" (USD) ACC","BK4548":"巴美列捷福持仓","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","UWM":"罗素2000指数ETF两倍做多","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","TZA":"罗素2000指数三倍做空ETF"},"translate_title":"Sinopharmaceuticals (01177. HK): ESG performance recognized by S&P Global, FTSE Russell","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SPGI":1,"ESG":1,"IWM":1,"01177":0.9,"RWM":0.6,"SRTY":0.6,"TNA":0.6,"TWM":0.6,"TZA":0.6,"UWM":0.6,"IWO":0.6,"MNQmain":0.6,"MRTYmain":0.6,"IWN":0.6},"content_text":"格隆汇7月19日丨中国生物制药(01177.HK)宣布，集团凭借持续且稳定的环境、社会及企业管治(ESG)实践表现，已获得标普全球(S&P Global)、富时罗素(FTSE Russell)等多家全球可持续发展权威机构的认可。2024年7月，集团凭借在标普全球企业可持续发展评估(CSA)中的优异表现，从1,700余家企业中脱颖而出，成功入选标普全球《可持续发展年鉴(中国版)2024》，成为各行业表现最好的129家入选企业之一，这也是集团连续第二年入选该年鉴。CSA是全球规模最大的企业可持续发展实践年度评估之一。目前，集团CSA评分已稳步提升至55分，超过全球92%的同业企业，处于国际领先水平。2024年6月，集团凭借优异的ESG实践及表现，首次入选富时罗素社会责任指数(FTSE4GoodIndex)。FTSE4Good指数系列于2001年创立，是首个度量符合全球公认企业责任标准的公司表现的指数系列。企业需就多个企业责任主题落实相关措施，包括环境管理、缓解气候变化、反贪污腐败、维护人权、劳工权利和供应链的劳工标准等，并符合严格的全球准则，才能成为FTSE4Good指数的成份股。集团首次入选FTSE4Good指数并连续第二年入选标普全球《可持续发展年鉴(中国版)》，代表着国际资本市场专业机构对集团ESG实践表现的持续、高度认可。集团将坚守“健康科技，温暖更多生命”的初心，将ESG理念与发展战略融合，提升风险管理水平，推动业务稳健发展，为股东、患者、员工及社会各界创造长期价值。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2452441380"}